BIOTECH TARGET N V
MGNXBIOTECH TARGET N V serves as 10% Owner at MacroGenics, Inc. (MGNX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
BIOTECH TARGET N V's Insider Trading at MacroGenics, Inc. (MGNX)
Buys
13 · $38.60M
Sells
0 · $0.00
Total Shares Bought
3,904,399
Total Shares Sold
0
BIOTECH TARGET N V's Insider Trading at Esperion Therapeutics, Inc. (ESPR)
Buys
3 · $10.74M
Sells
0 · $0.00
Total Shares Bought
530,000
Total Shares Sold
0
Related Insiders
Benjamin Halladay
officer: Chief Financial Officer
ESPRSell · Mar 18, 2026
Sheldon L. Koenig
President and CEO
ESPRSell · Mar 18, 2026
Benjamin Looker
officer: General Counsel
ESPRSell · Mar 18, 2026
Thomas Spitznagel
Sr VP, Technical Ops
MGNXSell · Feb 12, 2026
James Karrels
SVP and CFO
MGNXSell · Feb 12, 2026
Ezio Bonvini
Sr VP, Research & CSO
MGNXSell · Feb 12, 2026
Jeffrey Stuart Peters
Senior VP, GC, and Secretary
MGNXSell · Feb 12, 2026
Beth Ann Smith
VP, Controller & Treasurer
MGNXSell · Feb 12, 2026